Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

Tanta University

Status and phase: Completed; Phase 3

Conditions: COVID

Treatments: Drug: Chloroquine or hydroxychloroquine; Drug: zinc

Study type: Interventional

Funder types: Other

Identifiers

NCT04447534

tanta zinc chloroquine

Details and patient eligibility

About

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.

Full description

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19. As, zinc may be of value in these cases and may be of value in enhancing chloroquine effect.

Enrollment: 191 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with positive COVID-19.

Exclusion criteria

• Contraindications or hypersensitivity to chloroquine.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

191 participants in 2 patient groups

Chloroquine or hydroxychloroquine

Experimental group

Description:

Chloroquine or hydroxychloroquine alone

Treatment:

Drug: Chloroquine or hydroxychloroquine

Chloroquine or hydroxychloroquine with zinc

Experimental group

Description:

Chloroquine or hydroxychloroquine with zinc

Treatment:

Drug: zinc

Drug: Chloroquine or hydroxychloroquine